期刊文献+

窄谱中波紫外线对寻常性银屑病患者外周血干扰素诱导的T细胞α趋化因子表达的影响 被引量:7

The effect of the NB-UVB on serum levels of IFN-inducible T cell alpha chemoattractant in psoriasis
原文传递
导出
摘要 目的探讨窄谱中波紫外线(NB-UVB)对寻常性银屑病患者外周血干扰素诱导的T细胞α趋化因子(I-TAC)表达的影响。方法采用夹心酶联免疫吸附试验(ELISA)检测正常人和寻常性银屑病患者NB-UVB治疗前后外周血I-TAC水平变化。结果寻常性银屑病患者血清I-TAC水平明显高于正常对照组(t=21.37,P<0.05)。经NB-UVB治疗36次后,银屑病患者I-TAC水平较治疗前明显下降(t=18.23,P<0.05),且治疗前后银屑病患者银屑病皮损面积严重度指数(PASI)评分与血清I-TAC水平呈正相关(r=0.293,P<0.05)。结论 NB-UVB可降低寻常性银屑病患者外周血I-TAC水平,在银屑病的发病过程中I-TAC可能发挥重要作用。 Objective To study the effect of the narrow-band ultraviolet B( NB-UVB) on serum levels of IFN-inducible T cell alpha chemoattractant(I-TAC) in psoriasis. Methods Sandwich enzyme-linked immunosorbent assay was used to detect peripheral blood levels of serum I-TAC in psoriasis vulgaris before and after the treatment of NB-UVB and healthy controls. Results The serum level of I-TAC was signifi cant higher in patients with psoriasis vulgaris than those in normal group(t=21.37, P0.05). After the treatment of NB-UVB for 36 times, I-TAC level in psoriasis patients was signifi cantly decreased compared with before the treatment(t=18.23, P0.05). PASI score of psoriasis patients, before and after the treatment, and serum I-TAC levels were positively correlated. Conclusion NB-UVB can reduce the serum level of I-TAC in patients with psoriasis vulgaris, and I-TAC may be involved in valueadded pathogenesis of psoriasis.
出处 《实用皮肤病学杂志》 2015年第2期92-94,共3页 Journal of Practical Dermatology
基金 陕西省教育厅专项科研计划项目(12JK0780)
关键词 银屑病 寻常性 中波紫外线 窄谱 T细胞α趋化因子 干扰素诱导 Psoriasis vulgaris Ultraviolet B narrow-band T cell alpha chemoattractant IFN-inducible
  • 相关文献

参考文献9

  • 1Wolfram JA, Diaconu D, Hatala DA, et al. Keratinocyte but not endothelial cell-specific overexpression of Tie2 leads to the development of psoriasis [J]. Am J Pathol, 2009, 174(4): 1443-1458.
  • 2刘海琴.窄谱中波紫外线对寻常性银屑病患者外周血T细胞CCR6表达的影响[J].中国皮肤性病学杂志,2011,25(11):851-853. 被引量:4
  • 3Sweeney CM, Tobin AM, Kirby B. Innate immunity in the pathogenesis of psoriasis [J]. Arch Dermatol Res, 2011, 303(10): 691-705.
  • 4吴剑,肖汀,王志华,吴严,何春涤,高兴华,陈洪铎.银屑病皮损中CXCL11/I-TAC及其受体CXCR3的表达[J].中国免疫学杂志,2009,25(5):462-463. 被引量:4
  • 5Muller M, Carter S, Hofer MJ, et al.Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCLI0 and CXCL11 in neuroimmunity-a tale of conflict and conundrum[J]. Neuropathol Appl Neurobiol, 2010, 36(5):368-387.
  • 6Tworek D, Kuna P, Mlynarski W, et al. MIG (CXCL9), IP-10 (CXCLI0) and I-TAC (CXCLll) concentrations after nasal allergen challenge in patients with allergic rhinitis [J]. Arch Med Sci, 2013, 9(5):849-853.
  • 7Whalen M, Gilleaudeau P, Krueger JG, et al. A single intradermal injection of IFN-y induces an inflammatory state in both non- lesional psoriatic and healthy skin [J]. J Invest Dermatol, 2012, 132(4):1177-1187.
  • 8Racz E, Prens EP, Kurek D, et al. Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Thl7 pathways [J]. J Invest Dermatol, 2011,131(7):1547-1558.
  • 9Pietrzak AT, Zalewska A, Chodorowska G, et al. Cytokines and antieytokines in psoriasis [J]. Clin Chim Acta, 2008, 394(1-2):7-21.

二级参考文献16

  • 1李家文,吴艳,李东升,谭志建.β趋化因子CCL20及其受体CCR6 mRNA在寻常性银屑病患者皮损中的表达[J].临床皮肤科杂志,2004,33(9):532-534. 被引量:5
  • 2樊昕,王刚,刘玉峰.寻常型银屑病患者趋化因子受体7表达及其意义探讨[J].中国皮肤性病学杂志,2006,20(12):724-726. 被引量:6
  • 3Cole K E, Strick C A, Paradis T Jet al. Interferon-inducible T cell alpha chemoattractant (I-TAC):a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CX- CR3 [J]. J Exp Med, 1998; 187(12) :2009-2021.
  • 4Tensen C P, Flier J, Vander raajj-helmer E Met al. Human IP-9: a keratinocyte-defived high affinity CXC chemokine ligand for the IP-10/MIG receptor (CXCR3) [J] .J Invest Dermatol, 1999; 112(5) :716-722.
  • 5Flier J, Boorsma D M, van Beek P Jet al. Differential expression of CX- CR3 targeting chemokines CXCL10, CXCL9, and CXCLll in different types of skin inflammation[J] .J Pathol,2001 ; 194 (4) :398--405.
  • 6Austin L M, Ozawa M, Kikuchi T et al. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type I cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytoxic T lymphocyte) and Th1 effector populations: a type 1 differentiation bias isalso measured in circulating blood T cells in psoriatic patients [J] .J Invest Dermatol, 1999; 113 (5) :752-759.
  • 7Khan A, Farah C S, Savage N W etal. Th1 cytokines in oral lichen planus. [J] .J Oral Pathol Med,2003;32(2) :77-83.
  • 8Albanesi C, Scarponi C, Sebastiani Set al. IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines [ J ]. J Immunol, 2000 ; 165 (3) : 1395-1402.
  • 9Xiao T, Kagami S, Saeki H etal. Both IL-4 and IL-13 inhibit the TNF-alpha and IFN-gamma enhanced MDC production in a human keratinocyte cell line, HaCaT ceils [ J ]. J Dermatol Sci, 2003 ; 31 (2) : 111-117.
  • 10Konur A, Schulz U, Eissner Get al. Interferon (IFN)-γ is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-y and tumor necrosis factor-a production[J]. Br J Dermatol,2005; 152(6) : 1134-1142.

共引文献6

同被引文献64

  • 1张丹,刘青,荣光辉.N B-UV B照射联合中药内服治疗寻常型银屑病疗效观察[J].医学信息(医学与计算机应用),2014(27):171-172. 被引量:2
  • 2江从军,刘贞富,徐秋梅,马利娟,余慧敏.生存素在寻常型银屑病皮损中的表达[J].中国麻风皮肤病杂志,2007,23(5):391-392. 被引量:7
  • 3Pacifico A, Lenne G. Evaluatinn of a skin protection cream for dry. skin in patients undergoing nan'nw band UVB phototherapy fin" psoriasis vnl- garis. G hal Dermatol Venereo1,2011,146:179-183.
  • 4Long JW, Tao J, Pi XM, et al. Effect of narrow-band UVB photothera- py on soluble cell adhesion molecules in patients with psoriasis vulgaris. J lnt Med Res,2010,38: 1507-1512.
  • 5Coimbra S, Oliveira H, Belo L, et al. Principal determinants of tile length of rqnission of psoriasis vulgaris after topical, NB-UVB, and pLI- VA therapy : a follow-up study. Am J Clin Dermatol ,2013 ,14 :49-53.
  • 6Beani JC. Jcanmougin M. Narrow-band UVB therapy in psoriasis vulgar- is: good practice guideline and recummendatitms of the French Society of Pllotodermatology. Ann Dermatul Vcnercul,2010,137:21-31.
  • 7Ying SY. Micro RNA protocols [M]. Humana Press Inc, 2008:1-13.
  • 8Pellegrino L, Jacob J, Roca-Alonso L, et al. Altered expression of the miRNA processing endoribonuclease Dicer has prognostic significance in human cancers [J]. Expert Rev Anticancer Ther, 2013, 13:21-27.
  • 9Pereira DM, Rodrigues PM, Borralho PM, et al. Delivering the promise of miRNA cancer therapeutics [J]. Drug Discov Today, 2013, 18:282-289.
  • 10Asrih M, Steffens S. Emerging role of epigenetics and miRNA in diabetic cardiomyopathy [J]. Cardiovasc Pathol, 2013, 22:117-125.

引证文献7

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部